Showing 81-90 of 2922 results for "".
- FDA Recalls Software Used with Surgical Navigation Systemhttps://practicalneurology.com/news/fda-grants-breakthrough-device-designation-for-alzheimers-disease-screening-test/2468857/Medtronic has recalled software used during biopsy procedures due to reports that the products—Synergy Cranial Software and StealthStation S7 Cranial Software—provided incorrect information that could result in serious or life-threatening harm to patients. The FDA has id
- Stem-Cell Transplants Delayed Disease Progression of Multiple Sclerosishttps://practicalneurology.com/news/stem-cell-transplants-delayed-disease-progression-of-multiple-sclerosis/2468861/January 25, 2019—As published in JAMA, interim results of the phase 2 MIST trial (NCT00273364) show that stem-cell treatment resulted in a signific
- New Study Will Evaluate Smart Watch Technology for Help in Preventing Strokeshttps://practicalneurology.com/news/new-study-will-evaluate-smart-watch-technology-for-help-in-preventing-strokes/2468864/January 21, 2019—A new study will analyze the impact of a smart watch (Apple, Cupertino, CA) on early detection and diagnosis of atrial fibrillation (AFib) and the potential to prevent stroke. The large-scale research will start later this year in the US and will be a pragmatic, randomized,
- FDA Approves Generic Vigabatrin for Complex Partial Seizureshttps://practicalneurology.com/news/fda-approves-generic-vigabatrin-for-complex-partial-seizures/2468865/January 21, 2019—The Food and Drug Administration (FDA) has approved generic vigabatrin 500 mg tablets for adjunctive treatment of patients with complex partial seizures, age 10 years and older, who have not responded adequately to other treatments. “We know there has been
Expanding the Scope of Neurology: An Interview with Ralph L. Sacco, MD
https://practicalneurology.com/columns/practice-management/expanding-the-scope-of-neurology-an-interview-with-ralph-l-sacco-md/30358/New AAN President sees collaboration and wellness as integral to the future of the specialty.Seeking Breakthroughs: The Physician Perspective
https://practicalneurology.com/columns/practice-management/the-physician-perspective/30193/A roundtable discussion with Claudia A. Chiriboga, MD, MPH; Jeffrey L. Cummings, MD, ScD; and Nir Lipsman, MD, PhDINTREPID (A randomized, double-blind, sham-controlled study of subthalamic nucleus (STN) deep brain stimulation (DBS) for the treatment of individuals with Parkinson disease; NCT01839396)
https://practicalneurology.com/diseases-diagnoses/movement-disorders/intrepid-subthalamic-nucleus-deep-brain-stimulation-parkinson-disease/48741/Jerrold L. Vitek, MD, PhD, Head of the Neurology Department at the University of Minnesota, Minneapolis, MN, provides an overview of the INTREPID clinical trial which assessed subthalamic nucleus deep brain stimulation in patients with Parkinson disease.About the Cover Artist: Purple Phoenix by Denis Ducreux, MD, PhD
https://practicalneurology.com/diseases-diagnoses/imaging-testing/about-the-cover-artist-purple-phoenix-by-denis-ducreux-md-phd/56388/Dr. Ducreux’s artwork originates in diffusion-based MRI studies that reveal the organization of white matter pathways.About the Cover Artist: Fatherhood by Bevan Choate, MD
https://practicalneurology.com/diseases-diagnoses/stroke/about-the-cover-artistifatherhoodi-by-bevan-choate-md/32198/Dr. Choate, a practicing urologist, turned to art while recovering from a stroke he experienced at age 35. He continues to use his art to advocate for those affected by brain injury.- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31063/Differentiating Cervical Radiculopathy from Shoulder Pathology in Upper Extremity PainDavid L. Lichten, MD, and Mitchell K. Freedman, DO highlight the complexities in diagnosing the origin of upper extremity pain, which can stem from the cervical spine, shoulder, or concurrently from both regions. A